NCT02556762 2024-02-06
SUMC-EC-002
Shantou University Medical College
Phase 3 Unknown
Clinical Trials
85 trialsNCT03503630 2024-01-31
Short-course Radiation Followed by mFOLFOX-6 Plus COMPOUND 2055269 for Locally-advanced Rectal Adenocarcinoma
American University of Beirut Medical Center
Phase 2 Unknown
NCT02037048 2024-01-08
FOLFOX-6 Induction Chemotherapy Followed by Esophagectomy and Post-operative Chemoradiotherapy in Patients With Esophageal Adenocarcinoma
Case Comprehensive Cancer Center
Phase 2 Unknown
NCT03729687 2023-11-30
LARCT-US
Uppsala University
Phase 2 Unknown
NCT06120127 2023-11-07
IMPROVE
Fudan University
Phase 2 Unknown
NCT05010434 2023-09-21
Sintilimab and Bevacizumab Combined With Radiotherapy for Advanced Hepatocellular Carcinoma
Sun Yat-sen University
Phase 2 Unknown
NCT05783076 2023-08-30
SBRT Plus vNKT for Pancreatic Cancer
Changhai Hospital
Phase 2 Unknown
NCT03790553 2023-08-03
Comparing 61.2 Gy Radiotherapy Dose Versus 50.4 Gy Radiotherapy Dose for Locally Advanced Esophageal Carcinoma
Fudan University
Phase 3 Unknown
NCT05603065 2023-06-29
TINES
First Affiliated Hospital Xi'an Jiaotong University
Phase 4 Unknown
NCT05868317 2023-05-22
Induction Chemotherapy Followed by Short Course Radiotherapy in Rectal Cancer
Salah Azaïz Cancer Institute
Phase 2 Unknown
NCT02288195 2023-05-12
CONVERT: Neoadjuvant Chemotherapy Alone Versus Preoperative Chemoradiation for Locally Advanced Rectal Cancer Patients
Sun Yat-sen University
Phase 3 Unknown
NCT04030260 2023-03-23
Regorafenib and PD-1 Antibody in Combination With Radiotherapy for pMMR/MSS Metastatic Colorectal Cancer
Sun Yat-sen University
Phase 2 Unknown
NCT02025036 2023-02-08
CRTCOESC
The First Affiliated Hospital of Henan University of Science and Technology
Phase 3 Unknown
NCT05225116 2023-02-08
Safety and Efficacy of Lenvatinib and Anti-PD1 Antibody Combined With Radiotherapy Neoadjuvant Treatment for Resectable Hepatocellular Carcinoma With PVTT
Beijing Tsinghua Chang Gung Hospital
Phase 1 Unknown
NCT02125396 2023-01-27
ARTC-HCC
Guangxi Medical University
Phase 3 Unknown
NCT05635149 2022-12-02
Predictive Factors for Outcomes of Fruquintinib Plus Immunotherapy in Colorectal Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Unknown
NCT04575922 2022-09-08
Nivolumab+Ipilimumab+RT in MSS mCRC
Massachusetts General Hospital
Phase 2 Unknown
NCT05394415 2022-05-27
LATE
Jiangsu Cancer Institute & Hospital
Phase 1/2 Unknown
NCT02839343 2022-05-24
Combination Chemotherapy With or Without Hypofractionated Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer
Alliance for Clinical Trials in Oncology
Phase 2 Unknown
NCT03868605 2022-04-20
Endoscopic Full Thickness Resection Versus Standard Therapy of the Colorectal Neoplasia
Military University Hospital, Prague
Phase NA Unknown
NCT05292417 2022-03-31
Radiotherapy in Combination With Sintilimab，GM-CSF and Fruquintinib in Patients With MSS mCRC
The First Affiliated Hospital of Xiamen University
Phase 2 Unknown
NCT05160727 2021-12-20
Radiotherapy Combined With Tislelizumab and Irinotecan in MSS/pMMR Recurrence and Metastatic Colorectal Cancer
Zhejiang Cancer Hospital
Phase 2 Unknown
NCT04851132 2021-06-22
Radiotherapy Plus Durvalumab in Elderly Esophageal Squamous Cell Carcinoma
ChineseAMS
Phase NA Unknown
NCT04810663 2021-03-23
Outcome of Radiation Therapy in Operated Gastric Cancer
Assiut University
Unknown
NCT03936179 2021-03-18
High Dose PET/CT-guided Intensity Modulated Radiotherapy and Concurrent Chemotherapy in Esophageal Cancer
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase NA Unknown
NCT04747951 2021-02-15
Total Neoadjuvant Therapy in Rectal Cancer Treatment
State Scientific Centre of Coloproctology, Russian Federation
Phase 4 Unknown
NCT02526953 2021-02-09
Efficacy Study of Chemoradiotherapy With or Without Paclitaxel in Squamous-cell Anal Carcinoma Patients
Blokhin's Russian Cancer Research Center
Phase 3 Unknown
NCT04103697 2021-02-09
RuCorT-01
Blokhin's Russian Cancer Research Center
Phase 3 Unknown
NCT04134897 2021-02-09
RuCorT-02
Blokhin's Russian Cancer Research Center
Phase 3 Unknown
NCT04135313 2021-02-09
RuCorT-03
Blokhin's Russian Cancer Research Center
Phase 3 Unknown
NCT04231552 2020-11-30
Preoperative Short Course Radiotherapy With Chemotherapy and Camerelizumab in Locally Advanced Rectal Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 1/2 Unknown
NCT04631757 2020-11-17
Conversion Therapy of Camrelizumab Plus Chemoradiotherapy in Participants With Initial Unresectable Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Unknown
NCT04602013 2020-10-26
Sintilimab Injection Combined With Concurrent CCRT in Locally Advanced Esophageal Squamous Cell Carcinoma
Sichuan Cancer Hospital and Research Institute
Phase 2 Unknown
NCT04104074 2020-07-07
Safety and Efficacy of Radiotherapy Plus Sintilimab for HCC With Portal Vein Tumor Thrombosis
Beijing Tsinghua Chang Gung Hospital
Phase 1 Unknown
NCT04333927 2020-06-23
ACCORD
Sun Yat-sen University
Phase 2 Unknown
NCT04404491 2020-05-27
Clinical Control Study of Immunotherapy and Concurrent Chemoradiotherapy in Patients With Esophageal Cancer Recurrence
The First Affiliated Hospital of Henan University of Science and Technology
Phase 3 Unknown
NCT02887313 2020-05-04
FOTAC
Sun Yat-sen University
Phase 2 Unknown
NCT03022734 2020-01-13
Short Course Radiotherapy, Unresectable Rectal Cancer, Liver Metastasis
Yonsei University
Phase 2 Unknown
NCT04193696 2020-01-09
RT+ Anti-PD-1 for Patients With Advanced HCC (RT+PD-1-HCC)
Guangxi Medical University
Phase 2 Unknown
NCT01863862 2019-03-29
Organ Preservation in Elderly Patients With Rectal Cancer
Maria Sklodowska-Curie National Research Institute of Oncology
Phase NA Unknown
NCT03823079 2019-01-30
Comparison of Interleukin-11 and rhTPO for Recurrent Colorectal Cancer Patients With Thrombocytopenia
Fudan University
Phase 2 Unknown
NCT02741856 2018-10-25
SCOPE2
Velindre NHS Trust
Phase 2/3 Unknown
NCT03561142 2018-06-19
CAO/ARO/AIO-16
University Hospital Tuebingen
Phase 2 Unknown
NCT03520257 2018-05-09
The Study of Apatinib Plus Radiotherapy vs. Apatinib in the Treatment of Hepatocellular Carcinoma With BCLC-C Stage I and Stage II Portal Vein Tumor Thrombus
Guangxi Medical University
Phase 2 Unknown
NCT00407186 2017-10-10
Randomized Phase III Trial of Adjuvant Chemotherapy or Chemoradiotherapy in Resectable Gastric Cancer (CRITICS)
Dutch Colorectal Cancer Group
Phase 3 Unknown
NCT02938195 2016-10-19
Phase II Study of Neo-adjuvant Chemoradiotherapy for Squamous Cell Esophageal Cancer
Shanghai Chest Hospital
Phase 2 Unknown
NCT02604615 2016-07-06
DCOECRT
The First Affiliated Hospital of Henan University of Science and Technology
Phase 3 Unknown
NCT02745561 2016-04-20
Endostatin in Combination With Oxaliplatin and Radiotherapy in Esophageal Cancer Patients.
Hangzhou Cancer Hospital
Phase 2 Unknown
NCT01914289 2016-03-31
Prognosis of Resection and Radiotherapy in the Treatment of Intrahepatic Cholangiocarcinoma Patients
Eastern Hepatobiliary Surgery Hospital
Phase NA Unknown
NCT00058474 2016-03-23
Radiation Therapy and Either Capecitabine or Fluorouracil With or Without Oxaliplatin Before Surgery in Treating Patients With Resectable Rectal Cancer
NSABP Foundation Inc
Phase 3 Unknown